Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation Research

• Publication date

  2010-09-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.110.226357PMID 20651284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating MicroRNAs in Patients With Coronary Artery Disease

  2010cited by this paper
• MiR423-5p As a Circulating Biomarker for Heart Failure

  2010cited by this paper
• Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.

  2010cited by this paper
• Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection

  2009cited by this paper
• Scale-Free Networks: A Decade and Beyond

  2009cited by this paper
• Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

  2009cited by this paper
• Proteomic analysis of the secretome of human umbilical vein endothelial cells using a combination of free‐flow electrophoresis and nanoflow LC‐MS/MS

  2009cited by this paper
• Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

  2009cited by this paper
• miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.

  2009cited by this paper
• Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.

  2009cited by this paper
• Circulating microRNAs, potential biomarkers for drug-induced liver injury

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Plasma miR-208 as a biomarker of myocardial injury.

  2009cited by this paper
• Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease: The Framingham Offspring Study

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• miR-126 regulates angiogenic signaling and vascular integrity.

  2008cited by this paper
• Toward microRNA-based therapeutics for heart disease: the sense in antisense.

  2008cited by this paper
• Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.

  2008cited by this paper
• Proteomics Identifies Thymidine Phosphorylase As a Key Regulator of the Angiogenic Potential of Colony-Forming Units and Endothelial Progenitor Cell Cultures

  2008cited by this paper
• The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.

  2008cited by this paper
• Large-Scale Mapping and Validation of Escherichia coli Transcriptional Regulation from a Compendium of Expression Profiles

  2007cited by this paper
• Network-based classification of breast cancer metastasis

  2007cited by this paper
• Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells

  2007cited by this paper
• Repression of protein synthesis by miRNAs: how many mechanisms?

  2007cited by this paper
• How to infer gene networks from expression profiles

  2007cited by this paper
• Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis

  2007cited by this paper
• Emerging role of microRNAs in cardiovascular biology.

  2007cited by this paper
• Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results From the Bruneck Study

  2007cited by this paper
• Soluble Receptor Activator of Nuclear Factor-&kgr;B Ligand and Risk for Cardiovascular Disease

  2007cited by this paper
• The diverse functions of microRNAs in animal development and disease.

  2006cited by this paper
• Proteomics-based Development of Biomarkers in Cardiovascular Disease

  2006cited by this paper
• Information-based clustering.

  2005cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005cited by this paper
• Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.

  2004cited by this paper
• Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data.

  2003cited by this paper
• Microparticles in cardiovascular diseases.

  2003cited by this paper
• Toll-like receptor 4 polymorphisms and atherogenesis.

  2002cited by this paper
• Toll-like receptor 4 polymorphisms and atherogenesis.

  2002cited by this paper
• An efficient algorithm for large-scale detection of protein families.

  2002cited by this paper
• Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals.

  2000cited by this paper
• Graph clustering by flow simulation

  2000cited by this paper
• Significance testing of information theoretic functionals

  1997cited by this paper
• Long-term complications of diabetes mellitus.

  1993cited by this paper
• [Long-term complications in diabetes mellitus].

  1989cited by this paper
• A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

  1982cited by this paper
• Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice

  1978cited by this paper

• The Central Role of Oxidative Stress in Diabetic Retinopathy: Advances in Pathogenesis, Diagnosis, and Therapy

  2026cites this paper
• Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment.

  2026cites this paper
• MicroRNAs and suicidality: a systematic review and bioinformatic evaluation

  2026cites this paper
• Insulin Resistance and Inflammation

  2026cites this paper
• Biomarkers for effective prognosis of polycystic ovary syndrome: a full review.

  2026cites this paper
• A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes.

  2026cites this paper
• Specific microRNAs for Heart Failure: Reference Values in Whole Blood

  2025cites this paper
• Exploring the role of miR-126 in diabetes and its complications: a comprehensive review

  2025cites this paper
• Plasma multi-omics and machine learning reveal predictive biomarkers for type 2 diabetes and retinopathy in Qatar biobank cohort

  2025cites this paper
• Novel Micro-Ribonucleic Acid Biomarkers for Early Detection of Type 2 Diabetes Mellitus and Associated Complications—A Literature Review

  2025cites this paper
• Circulating microRNA signatures as potential biomarkers differentiating diabetic, prediabetic, and healthy individuals

  2025cites this paper
• Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing

  2025cites this paper
• Advances in Therapeutic Targets and Traditional Chinese Medicine for Cardiomyopathy

  2025cites this paper
• The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells

  2025cites this paper
• Circulating Cell Free microRNAs in Women with Polycystic Ovary Syndrome: Advancing Towards Biomarker Discovery and Therapeutic Targets

  2025cites this paper
• Circulating miR-223-3p as an Independent Biomarker of Recurrent Thrombotic Risk After Ischemic Stroke

  2025cites this paper
• Transcriptomic Profiling of Mouse Mesenchymal Stem Cells Exposed to Metal-Based Nanoparticles

  2025cites this paper
• Generative prediction of causal gene sets responsible for complex traits

  2025cites this paper
• Impact of gestational and type 2 diabetes on fetal endothelial cell miRNA expression.

  2025cites this paper
• Biological Roles of Selected microRNAs in Glucose Metabolism as a Candidate Biomarker for Diabetes Mellitus

  2025cites this paper
• MicroRNA-126: A key regulator of angiogenesis, inflammation, and tumorigenesis - Exploring its multifaceted functions in vascular health and cancer.

  2025cites this paper
• The expression of circulating microRNA-486-5p is associated with common mental disorders in older adults

  2025cites this paper
• miRNA in the Progression of Diabetic Kidney Disease: New Insight

  2025cites this paper
• Emerging Biomarkers and Nanobiosensing Strategies in Diabetes

  2025cites this paper
• Profiling of Plasma Extracellular Vesicles miRNA Reveals the Association of miR-3120-5p with Type 2 Diabetes Mellitus.

  2025cites this paper
• Unraveling genetic and epigenetic interplay in type 2 diabetes mellitus and cardiovascular risk

  2025cites this paper
• MicroRNA-126: From biology to therapeutics.

  2025cites this paper
• Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism

  2025cites this paper
• MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy

  2025cites this paper
• Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs

  2025cites this paper
• Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes

  2025cites this paper
• From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure

  2025cites this paper
• Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis

  2025cites this paper
• Cardiovascular complications in Diabetes: The role of NLRP3 inflammasome and targeted interventions

  2025cites this paper
• Understanding Diabetes Mellitus: Complications, Novel targets and Advancement in Treatment Strategies

  2025cites this paper
• Unlocking the Diagnostic and Therapeutic Potential of microRNA in Diabetes: A Bibliometric and Visualized Analysis (2003–2023)

  2025cites this paper
• Endothelial dysfunction as a driver of microvascular injury in diabetic cardiomyopathy

  2025cites this paper
• MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid

  2025cites this paper
• The Impact of Microplastics on Biological Systems: A Focus on Extracellular Vesicles and miRNA Profiles

  2025cites this paper
• Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review

  2025cites this paper
• Diagnostic Value and Mechanism of Action of Serum miR‐1281 Involved in T2DM and Complications of DKD

  2025cites this paper
• Platelets and inflammation—insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial

  2025cites this paper
• “Circulating MiRNAs targeting antioxidant genes: potential biomarkers for type 2 diabetes mellitus”

  2025cites this paper
• The inflammatory-miRNA axis in diabetic microvascular complications: a meta-analysis highlighting synergistic effects in concurrent retinopathy and nephropathy

  2025cites this paper
• The MiR-139-5p and CXCR4 axis may play a role in high glucose-induced inflammation by regulating monocyte migration

  2025cites this paper
• Circulating microRNAs and physical activity: Impact in diabetes.

  2025cites this paper
• Serum adropin and miR-21 expression as predictors of endothelial dysfunction in type 2 diabetes mellitus and vascular complications

  2025cites this paper
• MiRNA-27a-5p alleviates diabetic vascular injury via modulating autophagy by targeting NOX4.

  2025cites this paper
• The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction

  2024cites this paper
• miR-124, miR-126-3p, and miR-200b: Potential therapeutic targets for VEGF-mediated complications in proliferative diabetic retinopathy

  2024cites this paper
• Involvement of circulating microRNAs in the pathogenesis of atherosclerosis in young patients with obesity.

  2024cites this paper
• MicroRNAs as diagnostic biomarkers in diabetes male infertility: a systematic review

  2024cites this paper
• Circulating hsa-miR-320a and its regulatory network in type 1 diabetes mellitus

  2024cites this paper
• miR-320b, a Future Expected New Biomarker for Type 2 Diabetes Mellitus Induces Dysglycemia by Targeting PTEN

  2024cites this paper
• MicroRNA-24 therapeutic potentials in infarction, stroke, and diabetic complications

  2024cites this paper
• Assessment of NanoString technology as a tool for profiling circulating miRNA in maternal blood during pregnancy

  2024cites this paper
• Transcriptomic Profile of Lin−Sca1+c-kit (LSK) cells in db/db mice with long-standing diabetes

  2024cites this paper
• Anti‐inflammatory effects of kawakawa (Piper excelsum): An integrative mRNA–miRNA approach

  2024cites this paper
• Gut Microbiota–microRNA Interactions and Obesity Pathophysiology: A Systematic Review of Integrated Studies

  2024cites this paper
• Role of MicroRNA in linking diabetic retinal neurodegeneration and vascular degeneration

  2024cites this paper
• Platelet-derived microvesicles isolated from type-2 diabetes mellitus patients harbour an altered miRNA signature and drive MDA-MB-231 triple-negative breast cancer cell invasion

  2024cites this paper
• Insight into endothelial cell-derived extracellular vesicles in cardiovascular disease: Molecular mechanisms and Clinical implications.

  2024cites this paper
• Study on the Mechanism of miR-7562 Regulating ATG5 and ATG12 Genes in Penaeus monodon under Vibrio harveyi Infection.

  2024cites this paper
• Comparative studies of hair shaft components between healthy and diseased donors

  2024cites this paper
• Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review

  2024cites this paper
• Evaluating and Comparing Expression Levels of miR-199a and miR-126 in Peripheral Blood of Patients with Lone Atrial Fibrillation and Healthy Controls

  2024cites this paper
• Endothelial dysfunction: molecular mechanisms and clinical implications

  2024cites this paper
• MicroRNA-126 (MiR-126): key roles in related diseases

  2024cites this paper
• Diabetes risk reduction diet and colorectal cancer risk.

  2024cites this paper
• Advances in the study of microparticles in diabetic retinopathy.

  2024cites this paper
• MicroRNAs and Cardiovascular Disease Risk

  2024cites this paper
• Unveiling the regulatory role of miRNAs in stroke pathophysiology and diagnosis.

  2024cites this paper
• The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review

  2024cites this paper
• Transcriptomic Profile of Lin-Sca1+c-kit (LSK) cells in db/db mice with long-standing diabetes

  2024cites this paper
• Expression of Circulating miR-21 and -29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy.

  2024cites this paper
• Advances in Research Related to MicroRNA for Diabetic Retinopathy

  2024cites this paper
• Colorimetric and fluorescent dual-biosensor based on zirconium and preasodium metal-organic framework (zr/pr MOF) for miRNA-191 detection

  2024cites this paper
• Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease

  2024cites this paper
• Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers

  2024cites this paper
• Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets

  2024cites this paper
• Pharmacological and molecular mechanisms of miRNA-based therapies for targeting cardiovascular dysfunction.

  2024cites this paper
• Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study

  2024cites this paper
• Longitudinal associations between microRNAs and weight in the diabetes prevention program

  2024cites this paper
• Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults

  2024cites this paper
• Analysis of Circulating miRNA Expression Profiles in Type 2 Diabetes Patients with Diabetic Foot Complications

  2024cites this paper
• Association between expression level of the miR-320, miR-182, miR-223 and miR-486 and body composition among young Polish female volleyball players

  2024cites this paper
• Combination of Evidence from Bibliometrics and Bioinformatics Analysis Identifies miR-21 as a Potential Therapeutical Target for Diabetes

  2024cites this paper
• Therapeutic potential of adipose-derived stem cell extracellular vesicles: from inflammation regulation to tissue repair

  2024cites this paper
• In vitro anti-inflammatory activity of Malus × domestica var. Mela Rosa Marchigiana pulp callus extract contrasting high glucose conditions

  2024cites this paper
• Management of Microcomplications of Diabetes Mellitus: Challenges, Current Trends, and Future Perspectives in Treatment

  2024cites this paper
• Bibliometric Analysis of ncRNA Studies in Diabetes Mellitus With Coronary Heart Disease: A Visualization Approach

  2024cites this paper
• Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?

  2024cites this paper
• New insights on genetic background of major diabetic vascular complications

  2024cites this paper
• MicroRNA-mediated mechanisms in whole grain consumption for preventing type 2 diabetes mellitus

  2024cites this paper
• Understanding exosomes: Part 2-Emerging leaders in regenerative medicine.

  2024cites this paper
• MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis

  2024cites this paper
• Dysregulation of miR-25-3p in Diabetic Nephropathy and Its Role in Inflammatory Response

  2024cites this paper
• Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

  2023cites this paper
• New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review

  2023cites this paper
• Association of the circulating micro-RNAs with susceptible and newly diagnosed type 2 diabetes mellitus cases

  2023cites this paper